These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 135327)

  • 1. [Clinical trial of cinnarizine in some vascular diseases].
    Triandaf I; Cosma M; Triandaf N
    Rev Med Chir Soc Med Nat Iasi; 1976; 80(1):19-22. PubMed ID: 135327
    [No Abstract]   [Full Text] [Related]  

  • 2. [Cinnarizine and phosphatidyl choline in the treatment of cerebral arteriosclerotic pathology and arteriosclerosis of the lower extremities. Comparative study].
    Ciammaichella A; Solitro A; Arcuri P
    Minerva Cardioangiol; 1975 Mar; 23(3):191-200. PubMed ID: 1128771
    [No Abstract]   [Full Text] [Related]  

  • 3. [Sturgeron treatment effectiveness in early cerebral arteriosclerosis].
    Belonog RP; Karaban' IN
    Vrach Delo; 1980 Sep; (9):67-9. PubMed ID: 7423956
    [No Abstract]   [Full Text] [Related]  

  • 4. [Place of combined cinnarizine-heptanol acefyllinate in treatment of vertigo and ear buzzing of vascular origin].
    Calvet J; Coll J; Stefani JM
    J Fr Otorhinolaryngol Audiophonol Chir Maxillofac (1967); 1969 Feb; 18(2):127-30. PubMed ID: 4392741
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinicopharmacological examination of Stugeron (Cinnarizine) in geriatric patients.
    Graber H; Ternovszky E
    Ther Hung; 1978; 26(3):124-6. PubMed ID: 725815
    [No Abstract]   [Full Text] [Related]  

  • 6. [Experience in the treatment of leg ulcer with Stutgeron].
    Mund-Hoym WD
    Med Welt; 1976 Jun; 27(25):1251-4. PubMed ID: 933813
    [No Abstract]   [Full Text] [Related]  

  • 7. Peripheral vascular disease: cinnarizine et al.
    Drug Ther Bull; 1981 Mar; 19(7):27-8. PubMed ID: 7227205
    [No Abstract]   [Full Text] [Related]  

  • 8. [Comparison of the effectiveness of anginin and stugeron treatment of cerebral arteriosclerosis].
    Sobczyk W; Kruszewska J; Szymchel J
    Neurol Neurochir Pol; 1980; 14(2):183-9. PubMed ID: 6993976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical use of a new vasoactive drug : nicergoline].
    Mellini M
    Minerva Med; 1973 May; 64(34):1844-53. PubMed ID: 4719381
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effect of a single dose of cinnarizine on the peripheral flow and renogram of arteriosclerotic patients].
    Indovina I; Salerno L; Custro N
    Minerva Cardioangiol; 1980 May; 28(5):355-8. PubMed ID: 7207825
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effect of Cinnarizine in cerebral arteriosclerosis. Improvement of the clinical picture as a result of increased oxygen supply and utilization due to Cinnarizine].
    Reimann-Hunziker R; Reimann-Hunziker GJ
    Praxis; 1969 Sep; 58(39):1239-42. PubMed ID: 4899503
    [No Abstract]   [Full Text] [Related]  

  • 12. Cinnarizine in peripheral vascular insufficiency. Studies on blood flow, muscle capacity, and vascular tone.
    Schuermans V; Boermans A; Geivers H; Jageneau A; Brugmans J
    Arzneimittelforschung; 1971 Oct; 21(10):1541-3. PubMed ID: 5171882
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical evaluation of Cinnarizine in patients with peripheral vascular diseases].
    Simões Neto E
    Hospital (Rio J); 1971 Jan; 79(1):189-98. PubMed ID: 5316651
    [No Abstract]   [Full Text] [Related]  

  • 14. Controlled clinical trial of pentoxifylline versus cinnarizine in the treatment of labyrinthine disorders.
    Ganança MM; Mangabeira Albernaz PL; Caovilla HH; Ito YI
    Pharmatherapeutica; 1988; 5(3):170-6. PubMed ID: 3283777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical evaluation of cinnarizine in hyperlipaemic patients.
    Saba P; Galeone F; Salvadorini F; Guarguaglini M; Houben JL
    G Clin Med; 1974 Aug; 55(8):586-99. PubMed ID: 4377134
    [No Abstract]   [Full Text] [Related]  

  • 16. Therapeutic experience with Stugeron.
    Abrányi I
    Ther Hung; 1973; 21(3-4):117-20. PubMed ID: 4806419
    [No Abstract]   [Full Text] [Related]  

  • 17. Responsiveness of various symptoms of vascular disorders to calcium antagonist.
    Verhaegen H; Reyntjens A; Horig C; Pötsch W
    Angiology; 1979 Jul; 30(7):447-53. PubMed ID: 380409
    [No Abstract]   [Full Text] [Related]  

  • 18. [Comparison of the effectiveness of treatment with diverse doses of cinnarizine of patients with circulatory encephalopathy].
    Shtok VN; Fedorova NV; Pavlov IuV; Traĭtel' BIa
    Klin Med (Mosk); 1989 Sep; 67(9):55-8. PubMed ID: 2586043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Non-invasive diagnosis and medical therapy of cerebral and/or peripheral atherosclerotic vasculopathies].
    Rezzo R; Stabilini L; Bertoglio C; Ruben G; De Gregori M; Fontana G; Gori A; Petrilli GL
    Clin Ter; 1984 Dec; 111(6):495-511. PubMed ID: 6396028
    [No Abstract]   [Full Text] [Related]  

  • 20. [The use of cinnarizine in geriatrics].
    Pardo A; Agnello F
    G Gerontol; 1970 Oct; 18(10):936-40. PubMed ID: 5510623
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.